Robert Phelan Sells 10,000 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) CFO Robert Phelan sold 10,000 shares of the stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $126.21, for a total transaction of $1,262,100.00. Following the transaction, the chief financial officer directly owned 55,806 shares in the company, valued at $7,043,275.26. The trade was a 15.20% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

Shares of CVSA stock opened at $128.78 on Thursday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. Adtalem Global Education Inc. has a one year low of $86.97 and a one year high of $156.26. The stock’s 50-day moving average is $113.02. The company has a market capitalization of $4.38 billion, a PE ratio of 20.06, a price-to-earnings-growth ratio of 1.07 and a beta of 0.63.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping the consensus estimate of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business had revenue of $487.03 million for the quarter. During the same period in the previous year, the business posted $1.92 EPS. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, research analysts forecast that Adtalem Global Education Inc. will post 8.03 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CVSA. Zacks Research cut shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Wall Street Zen cut shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Truist Financial raised their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday. Barrington Research reissued an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a report on Friday, April 17th. Finally, Weiss Ratings initiated coverage on shares of Adtalem Global Education in a report on Wednesday, February 25th. They issued a “hold (c+)” rating on the stock. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, Adtalem Global Education currently has an average rating of “Moderate Buy” and an average target price of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.